Monday, November 19, 2018 - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TRUL.C) (TSXV: $KHRN.V) (TSXV: $N.V) - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TRUL.C) (TSXV: $KHRN.V) (TSXV: $N.V)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TRUL.C) (TSXV: $KHRN.V) (TSXV: $N.V)

This month’s cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa

Delta, Kelowna, BC - November 19, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences  an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TRUL.C) (TSXV: $KHRN.V) (TSXV: $N.V)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Today we will be looking at announcements from Trulieve Cannabis Corp. (CSE: TRUL), Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF) and Namaste Technologies Inc. (TSXV: N)(OTCMKTS: NXTTF).
Trulieve Cannabis Corp. today announced its financial results for the third quarter ended September 30, 2018.
Some of the Q3 2018 highlights included revenue growing from $23.3 million in Q2 2018 to $28.3 million in Q3 2018, adjusted EBITDA1,2 increased from $11.7 million in Q2 2018 to $12.6 million in Q3 2018 and the company began trading on the Canadian Securities Exchange.
"These outstanding results in Q3 demonstrate the meaningful progress we've made on our strategic plan since becoming a publicly-traded company in September," said Kim Rivers, CEO of Trulieve. "Looking ahead, we remain focused on scalable growth, including multi-state operational expansion."
Earlier this month, Trulieve announced the acquisition of Life Essence, Inc. and Leef Industries, LLC., based in Massachusetts and California respectively. These acquisitions mark the first operational initiatives beyond Florida for Trulieve.
"Trulieve's market-leading brand experience continues to result in high patient retention as we deliver consistent, high-quality products, supported by predictive analytics and industry-leading outreach while advocating for patients and physicians," Rivers continued. "We believe we are well-positioned in continuing to be the dominant leader in the Florida market while firmly establishing our footprint in the Massachusetts and California markets moving forward."
Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced that it has received additional quotas from the Colombian Technical Quotas Group ("TQG"), to cultivate 5,040 psychoactive cannabis plants for the purposes of completing the Colombian Agricultural Institute ("ICA") agronomic evaluation tests. This represents a key milestone towards Khiron's stated timeline to bring medical cannabis options to market in Colombia.
Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs commented, "This allocation of cultivation quotas allows us to continue with the process of presenting new cannabis strains to the ICA for testing and approval for commercial production. We expect to complete this current phase of the Colombian licensing process in the very near future and to use these strains for commercial purposes by Q1 of 2019."
With this test cultivation quota, Khiron, one of the first companies to be registered by the ICA as an agronomical unit, is positioned to ensure the availability of all genetic material required to finish the ICA's agronomical evaluation of more than 60 strains of cannabis that have proven to have genetic potential for medical development and that can be used for commercial purposes. The cultivation yield will also enable the company to begin building a seed bank for the future development of new medical cannabis products.
Namaste Technologies Inc. announced the launch of its Craft Cannabis Program with its preferred regulatory partners, Cannabis Compliance Inc. ("CCI"). The program is intended to provide support for craft cultivators who will apply for a micro-cultivator or micro-processor license under the Cannabis Act. Namaste's wholly-owned subsidiary, Cannmart Inc. has initiated a program that offers both regulatory and financial support to Micro Cultivators in exchange for a Supply Agreement with the right of first refusal ("ROFR") on 100% of their production. Cannmart will launch a Craft Cannabis section on its website that will offer patients access to a large variety of premium-quality cannabis products sourced from small-batch producers.
Each Micro Cultivator will be allowed to grow cannabis up to 200 square meters (2152 square feet) of total canopy space. Each Micro Processor will be allowed to process up to 600kg of cannabis from their facility. By securing Supply Agreements with Micro Cultivators, Cannmart will provide its patients with access to many strains which have not yet been available in the regulated market. Cannmart's Craft Cannabis Program offers significant value for future Micro Cultivators not only by providing regulatory and financial support but also by providing a sales channel directly to consumers, with a healthy margin and national exposure. Craft growers across the country are now allowed to apply for a Micro Cultivator license under the new regulations of the Cannabis Act.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit:
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more podcasts visit:
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: Learn more about Investor ideas podcast and news publication services and costs
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.
Please read privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media

No comments:

Post a Comment